PROCEPT BioRobotics to Present at Upcoming 36th Annual Piper Sandler Healthcare Conference on December 4, 2024
PROCEPT BioRobotics to Present at Upcoming 36th Annual Piper Sandler Healthcare Conference on December 4, 2024
PROCEPT BioRobotics is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. The HYDROS Robotic System is the only AI-Powered, robotic technology that delivers Aquablation therapy. PROCEPT BioRobotics designed Aquablation therapy to deliver effective, safe, and durable outcomes for males suffering from lower urinary tract symptoms or LUTS, due to BPH that are independent of prostate size and shape or surgeon experience. BPH is the most common prostate disease and impacts approximately 40 million men in the United States. The Company has developed a significant and growing body of clinical evidence with over 150 peer-reviewed publications, supporting the benefits and clinical advantages of Aquablation therapy.SAN JOSE, Calif., Nov. 26, 2024 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today announced that members of management will present at the upcoming 36th Annual Piper Sandler Healthcare Conference in New York City. Management is scheduled to present on Wednesday, December 4 at 8:30 a.m. Eastern Time.
加利福尼亞州聖荷西，2024年11月26日（環球新聞）-- PROCEPt 機器人公司（納斯達克：PRCT）（"公司"），是一家專注於通過開發變革性泌尿外科解決方案來推進患者護理的外科機器人公司，今天宣佈管理層成員將在即將舉行的第36屆派傑投資醫療會議上發表演講，會議將在紐約市舉行。管理層計劃於東部時間12月4日星期三上午8:30進行演講。
A live webcast of each event, as well as an archived recording, will be available on the "Investors" section of the company's website at: . The webcasts will be archived and available for replay for at least 90 days after the event.
每個活動的現場直播，以及錄製的存檔，將在公司網站的「投資者」部分可用。網絡直播將被存檔，並在活動結束後至少可回放90天。
About PROCEPT BioRobotics Corporation
關於PROCEPt 機器人公司
PROCEPT BioRobotics is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. The HYDROS Robotic System is the only AI-Powered, robotic technology that delivers Aquablation therapy. PROCEPT BioRobotics designed Aquablation therapy to deliver effective, safe, and durable outcomes for males suffering from lower urinary tract symptoms or LUTS, due to BPH that are independent of prostate size and shape or surgeon experience. BPH is the most common prostate disease and impacts approximately 40 million men in the United States. The Company has developed a significant and growing body of clinical evidence with over 150 peer-reviewed publications, supporting the benefits and clinical advantages of Aquablation therapy.
PROCEPt 機器人公司是一家專注於通過開發變革性泌尿外科解決方案來推進患者護理的外科機器人公司。HYDROS機器人系統是唯一一種人工智能驅動的機器人科技，能夠提供水刀治療。PROCEPt 機器人公司設計水刀治療以爲男性提供有效、安全和持久的治療結果，適用於因良性前列腺增生（BPH）引起下尿路症狀（LUTS）的患者，這與前列腺的大小和形狀或外科醫生的經驗無關。良性前列腺增生是最常見的前列腺疾病，影響美國大約4000萬男性。公司已經開發出一份重要且日益增長的臨床證據，擁有超過150篇經過同行評審的出版物，支持水刀治療的好處和臨床優勢。
Investor Contact:
Matt Bacso
VP, Investor Relations and Business Operations
m.bacso@procept-biorobotics.com
投資者聯繫人：
馬特·巴克索
副總裁，投資者關係和業務運營
m.bacso@procept-biorobotics.com
譯文內容由第三人軟體翻譯。